My prescriber ordered three tests and this board recommends about twenty, and I would like to know which of those two lists is right.
So the question, as narrowly as I can put it: how often to repeat it, because quarterly seems to be the convention and I cannot find the reasoning.
Numbers rather than impressions, if you have them.
Taking the question as asked, rather than the general version of it. The single most useful discipline is bringing the whole panel to a clinician rather than one flagged value. One out-of-range result in isolation generates anxiety and unnecessary tests; the same result next to the trend and the rest of the panel usually generates a shrug.
BethLabQueen said:The single most useful discipline is bringing the whole panel to a clinician rather than one flagged value.
Agreeing with BethLabQueen, and the qualification matters more than the agreement. One addition: if the lab changes analytical platform between your draws, the comparison breaks and nobody tells you. It is worth asking when a value moves inexplicably.
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View Resultssophie_paris said:My prescriber ordered three tests and this board recommends about twenty, and I would like to know which of those two lists is right.
Can confirm the pattern sophie_paris describes. Quarterly for the first year is convention rather than evidence, and it is defensible for a simple reason: it is roughly the interval over which HbA1c becomes informative again, since it reflects about three months of glycaemia. After the first year, and once doses are stable, annual is reasonable unless something specific is being followed.
Adding the clinical framing, because it changes how the question reads.
Blood work came back perfect. baseline bloodwork + this community = winning. 🏆